| http://www.w3.org/ns/prov#value | - Finally, in absence of controlled clinical studies to evaluate nosode protection in the face of low-grade infection and the improbability of assuring that an individual dog is only exposed to low levels of a particular pathogen, to date the safest alternative for reducing risk of secondary vaccine side-effects while also providing effective protection is the use of alternate types of vaccines (i.e
|
